Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Clinical trial NCT04180813 · TERMINATED

Trial details

NCT number: NCT04180813
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2020-03-04
Primary completion: 2021-07-11
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.